The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats.

The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats.
复制标题

DOI:
10.1371/journal.pone.0066336
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Yu B
Yu B
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Zhang M;Zhang S;Wu J;Sun Y;Li L;Du W;Liu J;Hou J;Yu B

文献摘要

参考文献

相似文献

原苏木素A(Protosappanin A,PrA)是中药云实(Caesalpinia cerean L.)的一种免疫抑制成分,可能通过损害抗原提呈细胞(antigen presenting cells,APC)的功能而抑制大鼠心脏移植物的存活。我们研究了PrA对树突状细胞(DCs)成熟和功能的影响,树突状细胞是一种有效的APC,以及介导PrA免疫抑制活性的下游细胞-细胞和细胞内信号传导途径。PrA抑制LPS刺激的Wistar大鼠DCs体外成熟,表现为共刺激分子(CD 80和CD 86)表达减少以及TLR 4和NF-κB(抗原识别的两个关键信号组分)表达减少。PrA还可促进DC释放IL-10,减少IL-12,但对TGF-β的产生无影响。在混合培养中,用PrA预处理的Wistar DC损害了Sprague道利(SD)大鼠T细胞的增殖,同时促进SD大鼠CD 4 + CD 25+调节性T细胞(T细胞)的扩增。口服PrA治疗和输注PrA预处理的Wistar DC均延长了心脏同种异体移植物存活(Wistar供体,SD受体)和扩增的受体CD 4 + CD 25 + Foxp 3 + T细胞。供体脾细胞,而不是来自第三大鼠品系(DA)的脾细胞,支持受体CD 4 + CD 25 + Foxp 3 + T细胞的扩增并抑制受体T细胞增殖。我们的结论是,PrA触发的致耐受性的状态,允许诱导同种异体抗原特异性Tclase和同种异体移植排斥反应的抑制在体内的DC。
Protosappanin A (PrA), an immunosuppressive ingredient of the medicinal herb Caesalpinia sappan L, prolongs heart allograft survival in rats, possibly by impairing the function of antigen-presenting cells (APCs). We examined the effects of PrA on the maturation and function of dendritic cells (DCs), a potent class of APCs, and the downstream cell–cell and intracellular signaling pathways mediating the immunosuppressive activity of PrA. PrA inhibited LPS-stimulated maturation of Wistar rat DCs in vitro as reflected by reduced expression of costimulatory molecules (CD80 and CD86) and reduced expression of TLR4 and NF-κB, two critical signaling components for antigen recognition. PrA also enhanced the release of IL-10 and decreased the release of IL-12 from DCs, but had no effect on the production of TGF-ß. In mixed cultures, Wistar DCs pretreated with PrA impaired the proliferation of Sprague Dawley (SD) rat T cells while promoting the expansion of SD rat CD4+CD25+ regulatory T cells (Tregs). Both oral PrA treatment and infusion of PrA-pretreated Wistar DCs prolonged cardiac allograft survival (Wistar donor, SD recipient) and expanded recipient CD4+CD25+Foxp3+ Tregs. Donor spleen cells, but not spleen cells from a third rat strain (DA), supported the expansion of recipient CD4+CD25+Foxp3+ Tregs and suppressed recipient T cell proliferation. We conclude that PrA triggers a tolerogenic state in DCs that allows for the induction of alloantigen-specific Tregs and the suppression of allograft rejection in vivo.
DOI: 10.1111/j.1600-6143.2004.00683.x
发表时间: 2005-02-01
影响因子: 8.8
作者:
Pêche, H;Trinité, B;Cuturi, MC
通讯作者: Cuturi, MC
DOI: 10.4049/jimmunol.0903412
发表时间: 2010-01-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Caretto D;Katzman SD;Villarino AV;Gallo E;Abbas AK
通讯作者: Abbas AK
DOI: 10.1111/j.1432-2277.2007.00537.x
发表时间: 2007-10-01
影响因子: 3.1
作者:
Braudeau, Cecile;Racape, Maud;Brouard, Sophie
通讯作者: Brouard, Sophie
DOI: 10.1189/jlb.1011500
发表时间: 2012-04-01
影响因子: 5.5
作者:
Hattori, Takaaki;Saban, Daniel R.;Dana, Reza
通讯作者: Dana, Reza
DOI: 10.4049/jimmunol.169.6.3382
发表时间: 2002-09-15
影响因子: 4.4
作者:
Bonham, CA;Peng, LS;Lu, L
通讯作者: Lu, L